Related references
Note: Only part of the references are listed.Improvement in psoriasis after treatment with the glucagon-like peptide-1 receptor agonist liraglutide
A. Faurschou et al.
ACTA DIABETOLOGICA (2014)
Diagnosis and classification of psoriasis
Smriti K. Raychaudhuri et al.
AUTOIMMUNITY REVIEWS (2014)
Liraglutide in combination with acitretin for severe recalcitrant psoriasis
C. T. Reid et al.
BRITISH JOURNAL OF DERMATOLOGY (2013)
Increased expression of glucagon-like peptide-1 receptors in psoriasis plaques
Annesofie Faurschou et al.
EXPERIMENTAL DERMATOLOGY (2013)
Glucagon-like peptide-1 analogue therapy for psoriasis patients with obesity and type 2 diabetes: a prospective cohort study
T. Ahern et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2013)
Sitagliptin, a Dipeptidyl Peptidase-IV Inhibitor, Improves Psoriasis
Tatsuya Nishioka et al.
DERMATOLOGY (2012)
Improvement of psoriasis during exenatide treatment in a patient with diabetes
M. Buysschaert et al.
DIABETES & METABOLISM (2012)
Glucagon-like peptide-1 (GLP-1) receptor agonists, obesity and psoriasis: diabetes meets dermatology
D. J. Drucker et al.
DIABETOLOGIA (2011)
Glucagon-like peptide-1 (GLP-1) and the regulation of human invariant natural killer T cells: lessons from obesity, diabetes and psoriasis
A. E. Hogan et al.
DIABETOLOGIA (2011)
Gastric bypass surgery: Improving psoriasis through a GLP-1-dependent mechanism?
Annesofie Faurschou et al.
MEDICAL HYPOTHESES (2011)
Medical progress - Psoriasis
MP Schon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Share Paper
